Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of Pathogen-Related receptors but dependent on amino acid sequence variations of IAV NS1

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 8843-8852

  Nacken, Wolfgang ^a   Anhlan, Darisuren ^a   Hrincius, Eike R ^a,e   Mostafa, Ahmed ^b,d   Wolff, Thorsten ^c   Sadewasser, Anne ^c   Pleschka, Stephan ^d   Ehrhardt, Christina ^a   Ludwig, Stephan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c ROBERT KOCH INSTITUTE   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 30; CYCLOHEXIMIDE; MDA5 PROTEIN; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NONSTRUCTURAL PROTEIN 1; PHENYLALANINE; RETINOIC ACID INDUCIBLE PROTEIN I; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DEAD-BOX RNA HELICASES; DOGS; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MADIN DARBY CANINE KIDNEY CELLS; MUTAGENESIS, SITE-DIRECTED; MYELOID DIFFERENTIATION FACTOR 88; ORTHOMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; TRETINOIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84904861787     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00424-14     Document Type: Article

References (47)

1. Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS. 1999. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J. Virol. 73:1023-1035.
2. McLean TI, Bachenheimer SL. 1999. Activation of c-Jun N-terminal kinase by herpes simplex virus type 1 enhances viral replication. J. Virol. 73:8415-8426.
3. Clarke P, Meintzer SM, Widmann C, Johnson GL, Tyler KL. 2001. Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun. J. Virol. 75:11275-11283. http://dx.doi.org/10.1128/JVI.75.23.11275-11283.2001.
4. Hamza MS, Reyes RA, Izumiya Y, Wisdom R, Kung HJ, Luciw PA. 2004. ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway. J. Biol. Chem. 279:38325-38330. http://dx.doi.org/10.1074/jbc.M400964200.
5. Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T. 2000. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J. Immunol. 164:3222-3228. http://dx.doi.org/10.4049/jimmunol.164.6.3222.
6. Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S. 2001. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276:10990-10998. http://dx.doi.org/10.1074/jbc.M009902200.
7. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, Planz O, Pleschka S, García-Sastre A, Heins G, Wolff T. 2002. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76:11166-11171. http://dx.doi.org/10.1128/JVI.76.21.11166-11171.2002.
8. Nacken W, Ehrhardt C, Ludwig S. 2012. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses. Biol. Chem. 393:525-534. http://dx.doi.org/10.1515/hsz-2011-0270.
9. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216. http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359.
10. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511. http://dx.doi.org/10.1038/nri1391.
11. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65. http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x.
12. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28. http://dx.doi.org/10.1016/j.immuni.2005.04.010.
13. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
14. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
15. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG. 1998. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63:609-620. http://dx.doi.org/10.1101/sqb.1998.63.609.
16. Honda K, Yanai H, Takaoka A, Taniguchi T. 2005. Regulation of the type I IFN induction: a current view. Int. Immunol. 17:1367-1378. http://dx.doi.org/10.1093/intimm/dxh318.
17. Hale BG, Randall RE, Ortín J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-2376. http://dx.doi.org/10.1099/vir.0.2008/004606-0.
18. Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S. 2009. Interplay between influenza A virus and the innate immune signaling. Microbes Infect. 1:81-87. http://dx.doi.org/10.1016/j.micinf.2009.09.007.
19. Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. 2010. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J. Virol. 84:11323-11335. http://dx.doi.org/10.1128/JVI.01034-10.
20. Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Högner K, Herold S, Ludwig S, Wolff T, Yu K, Richt JA, Planz O, Pleschka S. 2010. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J. Virol. 84:2122-2133. http://dx.doi.org/10.1128/JVI.01668-09.
21. Hrincius ER, Wixler V, Wolff T, Wagner R, Ludwig S, Ehrhardt C. 2010. CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses. Cell. Microbiol. 12:831-843. http://dx.doi.org/10.1111/j.1462-5822.2010.01436.x.
22. Tang ED, Wang CY. 2009. MAVS self-association mediates antiviral innate immune signaling. J. Virol. 83:3420-3248. http://dx.doi.org/10.1128/JVI.02623-08.
23. Mostafa A, Kanrai P, Ziebuhr J, Pleschka S. 2013. Improved dual promoter-driven reverse genetics system for influenza viruses. J. Virol. Methods 193:603-610. http://dx.doi.org/10.1016/j.jviromet.2013.07.021.
24. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113. http://dx.doi.org/10.1073/pnas.100133697.
25. Barber MR, Aldridge JR, Jr, Webster RG, Magor KE. 2010. Association of RIG-I with innate immunity of ducks to influenza. Proc. Natl. Acad. Sci. U. S. A. 107:5913-5918. http://dx.doi.org/10.1073/pnas.1001755107.
26. Davis WG, Bowzard JB, Sharma SD, Wiens ME, Ranjan P, Gangappa S, Stuchlik O, Pohl J, Donis RO, Katz JM, Cameron CE, Fujita T, Sambhara S. 2012. The 3' untranslated regions of influenza genomic sequences are 5'PPP-independent ligands for RIG-I. PLoS One 7(3):e32661. http://dx.doi.org/10.1371/journal.pone.0032661.
27. Barber MR, Aldridge JR, Jr, Webster RG, Magor KE. 2010. Association of RIG-I with innate immunity of ducks to influenza. Proc. Natl. Acad. Sci. U. S. A. 107:5913-5918. http://dx.doi.org/10.1073/pnas.1001755107.
28. Ochiai H, Sakai S, Hirabayashi T, Shimizu Y, Terasawa K. 1995. Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cell. Antiviral Res. 27:425-430. http://dx.doi.org/10.1016/0166-3542(95) 00040-S.
29. Geller R, Taguwa S, Frydman J. 2012. Broad action of Hsp90 as a host chaperone required for viral replication. Biochim. Biophys. Acta 1823: 698-706. http://dx.doi.org/10.1016/j.bbamcr.2011.11.007.
30. Zhang C, Yang Y, Zhou X, Yang Z, Liu X, Cao Z, Song H, He Y, Huang P. 2011. The NS1 protein of influenza A virus interacts with heat shock protein Hsp90 in human alveolar basal epithelial cells: implication for virus-induced apoptosis. Virol. J. 8:181. http://dx.doi.org/10.1186/1743-422X-8-181.
31. Twu KY, Noah DL, Rao P, Kuo RL, Krug RM. 2006. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J. Virol. 80:3957-3965. http://dx.doi.org/10.1128/JVI.80.8.3957-3965.2006.
32. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol. Cell 1:991-1000. http://dx.doi.org/10.1016/S1097-2765(00)80099-4.
33. Das K, Ma LC, Xiao R, Radvansky B, Aramini J, Zhao L, Marklund J, Kuo RL, Twu KY, Arnold E, Krug RM, Montelione GT. 2008. Structural basis for suppression of a host antiviral response by influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 105:13093-13098. http://dx.doi.org/10.1073/pnas.0805213105.
34. Ramos HJ, Gale M, Jr. 2011. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr. Opin. Virol. 1:167-176. http://dx.doi.org/10.1016/j.coviro.2011.04.004.
35. Ehrhardt C, Ludwig S. 2009. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell. Microbiol. 11:863-871. http://dx.doi.org/10.1111/j.1462-5822.2009.01309.x.
36. Ehrhardt C, Marjuki H, Wolff T, Nürnberg B, Planz O, Pleschka S, Ludwig S. 2006. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell. Microbiol. 8:1336-1348. http://dx.doi.org/10.1111/j.1462-5822.2006.00713.x.
37. Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, Ehrhardt C. 2011. Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Cell. Microbiol. 13:1907-1919. http://dx.doi.org/10.1111/j.1462-5822.2011.01680.x.
38. Ayllon J, Hale BG, García-Sastre A. 2012. Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence. J. Virol. 86:5366-5370. http://dx.doi.org/10.1128/JVI.06722-11.
39. Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO. 2011. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 85:7048-7058. http://dx.doi.org/10.1128/JVI.00417-11.
40. Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Högner K, Herold S, Ludwig S, Wolff T, Yu K, Richt JA, Planz O, Pleschka S. 2010. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J. Virol. 84:2122-2133. http://dx.doi.org/10.1128/JVI.01668-09.
41. Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. 2010. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J. Virol. 84:11323-11335. http://dx.doi.org/10.1128/JVI.01034-10.
42. Noronha JM, Liu M, Squires RB, Pickett BE, Hale BG, Air GM, Galloway SE, Takimoto T, Schmolke M, Hunt V, Klem E, García-Sastre A, McGee M, Scheuermann RH. 2012. Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restriction. J. Virol. 86:5857-5866. http://dx.doi.org/10.1128/JVI.06901-11.
43. Lam WY, Yeung AC, Chan PK. 2011. Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes. Virol. J. 8:554. http://dx.doi.org/10.1186/1743-422X-8-554.
44. Sutejo R, Yeo DS, Myaing MZ, Hui C, Xia J, Ko D, Cheung PC, Tan BH, Sugrue RJ. 2012. 2012. Activation of type I and III interferon signaling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS One 7(3):e33732. http://dx.doi.org/10.1371/journal.pone.0033732.
45. Munir M, Zohari S, Belák S, Berg M. 2012. Double-stranded RNAinduced activation of activating protein-1 promoter is differentially regulated by the non-structural protein 1 of avian influenza A viruses. Viral Immunol. 25:79-85. http://dx.doi.org/10.1089/vim.2011.0059.
46. Macken C, Lu H, Goodman J, Boykin L. 2001. In Osterhaus NC, Hampson AW (ed), Options for the control of influenza IV, vol IV, p 103-106. Elsevier Science, Amsterdam, Netherlands.
47. Kuo RL, Krug RM. 2009. Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells. J. Virol. 83:1611-1616. http://dx.doi.org/10.1128/JVI.01491-08.